This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose of methotrexate.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01008852?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
